Neurogene shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurogene by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 73k | 17.33 |
| 2025-03-31 | $248k | 21k | 11.71 |
| 2024-12-31 | $870k | 38k | 22.86 |
| 2024-09-30 | $1.7M | 41k | 41.96 |
| 2024-06-30 | $475k | 13k | 36.39 |
| 2024-03-31 | $3.8M | 74k | 50.90 |